| COVID-19 |
1 |
1 |
| Impairment |
0 |
0.65 |
| Cognitive Impairment |
0 |
0.6 |
| Obesity |
0 |
0.48 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.45 |
| Hospital |
0 |
0.99 |
| Quality of Life |
0 |
0.29 |
| Exercise |
0 |
0.26 |
| Mechanical Ventilation |
0 |
0.21 |
| Mild Cognitive Impairment |
0 |
0.21 |
| Biologic Therapy |
0 |
0.14 |
| UK Site Content |
0 |
0.13 |
| Pain Management |
0 |
0.12 |
| Myalgia |
0 |
0.11 |
| Blood |
0 |
0.07 |
| C-Reactive Protein (CRP) |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Fatigue |
0 |
0.07 |
| Genomic Medicine |
0 |
0.07 |
| Health Care Services |
0 |
0.07 |
| Interleukin |
0 |
0.07 |
| Microbiology |
0 |
0.07 |
| Microbiome |
0 |
0.07 |
| Muscle |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Post-Traumatic Stress Disorder |
0 |
0.07 |
| Precision Medicine |
0 |
0.07 |
| Sleep |
0 |
0.07 |
| Stress |
0 |
0.07 |